Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review

Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic

(2020) Peter J. Neumann et al.   HEALTH AFFAIRS

A systematic review of the quality and scope of economic evaluations in child oral health research

(2019) H. J. Rogers et al.   BMC Oral Health

Cost-effectiveness of psychotropic polypharmacy in routine schizophrenia care. Results of the ELAN prospective observational trial

(2018) Reinhold Kilian et al.   NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH

Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives

(2018) Matthew Sussman et al.   CEPHALALGIA

Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review

(2018) Jamison Pike et al.   Applied Health Economics and Health Policy

Cost-effectiveness of adult vaccinations: A systematic review

(2018) Andrew J. Leidner et al.   VACCINE

Vaccines are different: A systematic review of budget impact analyses of vaccines

(2017) Priscilla Magalhaes Loze et al.   VACCINE

A systematic review of economic evaluations of population-based sodium reduction interventions

(2017) Silvia F. Hope et al.   PLoS One

A Systematic Review of Health Economic Evaluation Studies Using the Patient’s Perspective

(2016) Bik-Wai Bilvick Tai et al.   VALUE IN HEALTH

A systematic review of economic evaluations assessing interventions aimed at preventing or treating pressure ulcers

(2015) Palfreyman Simon J. et al.   INTERNATIONAL JOURNAL OF NURSING STUDIES

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

(2015) Bernhard Ultsch et al.   PHARMACOECONOMICS

How to Estimate Productivity Costs in Economic Evaluations

(2014) Marieke Krol et al.   PHARMACOECONOMICS

National Advisory Groups and their role in immunization policy-making processes in European countries

(2013) H. Nohynek et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor–positive metastatic breast cancer in Canada

(2013) T.E. Delea et al.   Current Oncology

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

(2013) D. Husereau et al.   BMJ-British Medical Journal

The Cost Effectiveness of Human Papillomavirus Vaccines

(2012) Katherine Seto et al.   DRUGS

Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review

(2012) Sachiko Ozawa et al.   VACCINE

Do Productivity Costs Matter?

(2011) Marieke Krol et al.   PHARMACOECONOMICS

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE